Core Viewpoint - The company has decided to extend the duration of its eighth employee stock ownership plan by six months, from June 6, 2025, to December 6, 2025, following approval from the board of directors and the majority of plan participants [1][4][5]. Summary by Relevant Sections Employee Stock Ownership Plan - The eighth employee stock ownership plan was initially approved on May 18, 2021, and involved the purchase of a total of 8,132,600 shares through block trading [1][5]. - The original lock-up period for these shares was 24 months, ending on June 8, 2023, with a total duration of 48 months, set to expire on June 6, 2025 [1][5]. - The extension of the plan's duration is in accordance with the company's management rules, allowing for a single extension of up to six months, with a maximum of two extensions [2][5]. Board Meeting Resolutions - The board meeting held on June 6, 2025, was attended by all 11 directors, and the proposal to extend the employee stock ownership plan was unanimously approved [4][5]. - The meeting followed all legal and procedural requirements as stipulated by the Company Law and the company's articles of association [4]. Stock Option Plan Adjustment - The company has adjusted the exercise price of its 2024 stock option incentive plan from 12.23 yuan per share to 11.95 yuan per share due to a cash dividend distribution of 0.28 yuan per share [12][13][17]. - The adjustment was made in compliance with the relevant regulations and was authorized by the company's second temporary shareholders' meeting in 2025 [12][19]. - The adjustment will not significantly impact the company's financial status or operational results, nor will it affect the stability of the management team [18][19].

Core Viewpoint - The company has successfully achieved the conditions for the first exercise period of its 2024 stock option incentive plan, allowing 47 eligible participants to exercise a total of 678,041 stock options at a price of 11.25 yuan per share [4][19][42]. Group 1: Board Meeting Details - The third meeting of the company's third board of directors was held on June 5, 2025, with all 9 directors present [2][3]. - The meeting was legally valid and complied with relevant laws and regulations [3]. Group 2: Resolutions Passed - The board approved the proposal regarding the achievement of exercise conditions for the first exercise period of the 2024 stock option incentive plan, allowing 47 participants to exercise 678,041 options at 11.25 yuan each [4][19][42]. - The board also approved adjustments to the list of initial grant recipients, reducing the number from 50 to 49 and the total number of options from 1.95 million to 1.93 million due to one participant's departure and performance assessments [6][7][36]. Group 3: Legal and Financial Advisory - Legal opinions and independent financial advisory reports were obtained to ensure compliance with regulations regarding the stock option plan [6][14][47]. - The independent financial advisor confirmed that the conditions for the first exercise period had been met and that the arrangements were legally valid [47][48]. Group 4: Impact on Financials - If all options are exercised, the company's net assets will increase by approximately 7.628 million yuan, and the total number of shares will increase by 678,041 [42][43]. - The exercise of options will not significantly impact the company's shareholding structure or its compliance with listing requirements [43].

Core Viewpoint - The company is adjusting its 2024 stock option incentive plan performance assessment indicators due to unexpected impacts from macroeconomic conditions and industry environment changes, aiming to align employee motivation with achievable performance targets [6][12][13]. Group 1: Approval and Authorization of Adjustments - The company has completed necessary legal procedures for the adjustment of the stock option incentive plan, including approvals from the board and supervisory committee [4][5][12]. - The adjustments have been approved in multiple board meetings, with relevant legal opinions provided [4][6][12]. Group 2: Reasons for Adjustment - The company faces significant performance gaps due to external economic factors, necessitating a revision of performance targets to avoid negative incentives that could harm employee motivation and shareholder interests [7][12]. - The adjustment aims to balance strategic goals with achievable performance metrics, enhancing employee engagement and aligning interests among shareholders, the company, and incentive recipients [12][13]. Group 3: Main Content of Adjustments - The stock option plan will assess performance over three fiscal years (2024, 2025, 2026), with specific targets set for company-level, business unit-level, and individual performance [10][11]. - Company-level performance targets include a minimum revenue growth rate of 10% for 2024 based on 2023 revenue, with additional cumulative growth requirements for subsequent years [8][10]. - Individual performance assessments will be linked to the performance of the respective business unit and personal evaluation results, with specific metrics defined for evaluation [9][11]. Group 4: Impact of Adjustments - The revised performance indicators are designed to be challenging yet achievable, fostering motivation among middle management and key personnel, and ensuring alignment of interests [12][13]. - The adjustments do not involve changes to the grant price and are not expected to adversely affect the company's financial status or operational results [12].

| T2 | 深圳市南山区前海大道前海嘉里商务中心 | | 栋 | 1401A | 室 | 邮编： | | | --- | --- | --- | --- | --- | --- | --- | --- | | 518054 | | | | | | | | | 电话：(86-755) 21557000 传真：(86-755) 2155 7099 | | | | | | | | | 北京市竞天公诚（深圳）律师事务所 | | | | | | | | | 关于 | | | | | | | | | 深圳市远望谷信息技术股份有限公司 | | | | | | | | | 法律意见书 | | | | | | | | | 二〇二五年六月 | | | | | | | | | 北京 · 上海 · 深圳 · 成都 · 南京 · · 广州 · 三亚 · 香港 | | | | | | | 杭州 | | Beijing·Shanghai·Shenzhen·Chengdu·Nanjing·Hangzhou·Guangzhou·Sanya·Hong Kong | | | | | | | | | 目 | | | | | | 录 | | | 释 ...

陈克明食品股份有限公司 （2025 年修订稿） 陈克明食品股份有限公司（以下简称"公司"）为了进一步建立、健全公司 长效激励机制，吸引和留住优秀人才，充分调动公司管理层及核心骨干的积极性， 提高公司可持续发展能力，在充分保障股东利益的前提下，按照收益与贡献对等 原则，拟实施公司 2024 年股票期权激励计划（以下简称"本激励计划"、"期 权激励计划"）。为了保证本激励计划的顺利实施，现根据《中华人民共和国公 司法》《中华人民共和国证券法》《上市公司股权激励管理办法》《深圳证券交 易所股票上市规则》《深圳证券交易所上市公司自律监管指南第 1 号——业务办 理》等有关法律、行政法规、部门规章、规范性文件和深圳证券交易所的相关业 务规则（以下统称"适用法律"）以及《陈克明食品股份有限公司章程》的相关 规定，并结合公司实际情况，特制定《陈克明食品股份有限公司 2024 年股票期 权激励计划实施考核管理办法》（以下简称"本考核管理办法"）。 一、考核目的 制定本考核管理办法的目的是加强本激励计划执行的计划性，量化本激励计 划设定的具体目标，促进激励对象考核管理的科学化、规范化、制度化，确保实 现本激励计划的各项业绩指标 ...

Core Viewpoint - The company has adjusted its 2024 stock option incentive plan's performance assessment indicators to better align with current market conditions and internal performance expectations, aiming to enhance employee motivation and ensure sustainable development [5][15]. Group 1: Stock Option Incentive Plan Adjustments - The company approved the adjustment of the 2024 stock option incentive plan, reducing the number of stock options granted from 20 million to 19.65 million for 178 incentive targets [1][3]. - The stock option grant date is set for June 28, 2024, with a grant price adjusted from 7.43 yuan to 7.23 yuan, and subsequently to 6.93 yuan due to capital adjustments [4][3]. - The performance assessment indicators for the stock options have been revised to include both revenue growth and net profit growth, reflecting a more realistic approach given the current economic environment [12][15]. Group 2: Performance Assessment Criteria - The original performance assessment required a minimum revenue growth rate of 10% for 2024, with cumulative growth targets for subsequent years [6][8]. - The revised criteria now include a requirement for net profit growth, with specific targets set for 2025 and 2026, aiming to ensure that the performance goals are achievable and motivating for employees [8][12]. - The assessment will continue to evaluate company-level, business unit-level, and individual performance, linking the number of options exercisable to the achievement of these targets [7][9]. Group 3: Rationale for Adjustments - The adjustments were made in response to unexpected macroeconomic conditions and industry changes that have impacted performance, necessitating a more flexible and achievable set of goals [5][11]. - The company aims to maintain its market share and focus on high-end product development while ensuring that the incentive plan remains effective in motivating key employees [5][15]. - The adjustments are designed to prevent negative incentives that could arise from unattainable performance targets, thereby aligning the interests of employees, the company, and shareholders [15][16].

证券代码：002661 证券简称：克明食品 公告编号：2025-064 陈克明食品股份有限公司 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 一、监事会会议召开情况 陈克明食品股份有限公司（以下简称"公司"）第六届监事会第二十八次会 议于 2025 年 5 月 31 日以电子邮件、微信等形式发出通知，于 2025 年 6 月 6 日 上午以现场结合线上会议方式召开。本次会议由监事会主席舒畅女士召集并主持， 会议应出席监事 3 人，实际出席会议的监事 3 人。其中，舒畅女士、王冠群先生 以线上方式参加。 本次会议符合《中华人民共和国公司法》《中华人民共和国证券法》《深圳 证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等有关法 律、法规、规章及《公司章程》的规定。 二、监事会会议审议情况 （二）《关于延长为控股子公司提供财务资助期限的议案》 内容：经审核，监事会认为，本次公司延长为控股子公司兴疆牧歌提供财务 资助的期限，有助于促进兴疆牧歌稳定发展，符合公司和全体股东的利益，且风 险可控，不会对公司产生不利影响。本事项的审议、表决程序符合有关法 ...

证券代码：002161 证券简称：远望谷 公告编号：2025-037 深圳市远望谷信息技术股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 深圳市远望谷信息技术股份有限公司（以下简称"公司"）第八届董事会第 三次（临时）会议通知及补充通知于 2025 年 6 月 5 日以电话、电子邮件方式发 出，并于 2025 年 6 月 6 日以现场结合通讯表决的方式召开会议。本次会议应出 席的董事人数 7 人，实际出席会议的董事人数 7 人。本次会议由董事长徐超洋先 生召集并主持。本次会议的召集、召开和表决程序符合有关法律、法规和《深圳 市远望谷信息技术股份有限公司章程》的有关规定。经与会董事认真审议： 二、董事会会议审议情况 （一）会议以 4 票同意，0 票反对，0 票弃权的表决结果，审议通过了《关 于 <深圳市远望谷信息技术股份有限公司 ensp="ensp" 年股票期权激励计划="年股票期权激励计划" 草案 ="草案"> 及 关联董事孙迎军、马琳、陆智先生回避表决，本议案需提交股东大会审议。 详情请参见与本公告同日披露的《关于提请 ...

Core Viewpoint - The legal opinion letter from Shanghai Junlan Law Firm confirms that Zhongman Petroleum and Natural Gas Group Co., Ltd. has obtained the necessary approvals and authorizations for the cancellation of certain stock options under its 2022 stock option incentive plan, which will not significantly impact the company's financial status or the interests of its shareholders [1][4][5]. Group 1: Approval and Authorization - The cancellation of stock options has been approved and authorized according to the 2022 stock option incentive plan and relevant regulations [4][5]. - The company has received necessary guarantees regarding the authenticity and completeness of the documents provided to the law firm [2]. Group 2: Cancellation Details - The cancellation involves 56,900 stock options that were automatically forfeited by seven incentive participants who did not pay the exercise price [4]. - The cancellation will complete the implementation of the incentive plan, and it is confirmed that this action will not have a significant impact on the company's financial condition or operational results [4][5]. Group 3: Information Disclosure - The company will timely announce the resolutions of the board meeting and the details regarding the cancellation of stock options as required by the relevant regulations [4][5]. - The company has fulfilled its information disclosure obligations in accordance with the management measures and the incentive plan [5].

证券代码：300404 证券简称：博济医药 公告编号：2025-046 博济医药科技股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 博济医药科技股份有限公司（以下简称"公司"）于 2025 年 6 月 6 日召开 第五届董事会第十四次会议和第五届监事会第十三次会议，审议通过了《关于注 销部分股票期权的议案》，鉴于公司 2022 年股票期权激励计划的第二个行权期 已届满，公司部分激励对象在第二个行权期的行权额度未能全部行权，同意公司 注销其到期未行权的股票期权 235,240 份。现将有关情况公告如下： 一、公司激励计划概述及已履行的相关程序 公司<2022 年股票期权激励计划（草案）>及其摘要的议案》 《关于公司<2022 年 股票期权激励计划实施考核管理办法>的议案》 股票期权激励计划实施考核管理办法>的议案》 《关于提请股东大会授权董事会办 理 2022 年股权激励相关事宜的议案》，并出具《关于 2022 年股票期权激励计划 内幕信息知情人及激励对象买卖公司股票情况的自查报告》。 十七次会议审议通过了《关于调整 2022 年股票期权激励计划相 ...